PI4KB
| Official symbol: | PI4KB |
| Full name: | phosphatidylinositol 4-kinase beta |
| Location: | 1q21.3 |
| Also known as: | PI4K-BETA, PIK4CB, pi4K92 |
| Entrez ID: | 5298 |
| Ensembl ID: | ENSG00000143393 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 2.42 (Driver) | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 9 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 5 |
|
|
| Fusions detected in 4 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase |
| JensenLab PubMed score: | 71.33 (Percentile rank: 67.61%) |
| PubTator score: | 40.85 (Percentile rank: 64.59%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
